India · Delayed Price · Currency is INR Ajanta Pharma Statistics
Total Valuation
Ajanta Pharma has a market cap or net worth of INR 309.42 billion. The enterprise value is 303.79 billion.
| Market Cap | 309.42B |
| Enterprise Value | 303.79B |
Important Dates
The last earnings date was Sunday, July 27, 2025.
| Earnings Date | Jul 27, 2025 |
| Ex-Dividend Date | Nov 6, 2024 |
Share Statistics
| Current Share Class | 124.89M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.82% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 41.84M |
Valuation Ratios
The trailing PE ratio is 33.27 and the forward PE ratio is 28.37.
| PE Ratio | 33.27 |
| Forward PE | 28.37 |
| PS Ratio | 6.44 |
| PB Ratio | 8.16 |
| P/TBV Ratio | 8.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 32.67 |
| EV / Sales | 6.32 |
| EV / EBITDA | 23.29 |
| EV / EBIT | 26.03 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | n/a |
| Interest Coverage | 46.21 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 19.60% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 4.99M |
| Profits Per Employee | 965,891 |
| Employee Count | 9,628 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Ajanta Pharma has paid 2.68 billion in taxes.
| Income Tax | 2.68B |
| Effective Tax Rate | 22.38% |
Stock Price Statistics
The stock price has decreased by -19.71% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -19.71% |
| 50-Day Moving Average | 2,652.52 |
| 200-Day Moving Average | 2,698.01 |
| Relative Strength Index (RSI) | 32.06 |
| Average Volume (20 Days) | 4,347 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ajanta Pharma had revenue of INR 48.06 billion and earned 9.30 billion in profits. Earnings per share was 74.42.
| Revenue | 48.06B |
| Gross Profit | 36.55B |
| Operating Income | 11.67B |
| Pretax Income | 11.98B |
| Net Income | 9.30B |
| EBITDA | 12.92B |
| EBIT | 11.67B |
| Earnings Per Share (EPS) | 74.42 |
Balance Sheet
The company has 6.14 billion in cash and 509.20 million in debt, giving a net cash position of 5.63 billion.
| Cash & Cash Equivalents | 6.14B |
| Total Debt | 509.20M |
| Net Cash | 5.63B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 37.90B |
| Book Value Per Share | 301.59 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 76.05%, with operating and profit margins of 24.29% and 19.35%.
| Gross Margin | 76.05% |
| Operating Margin | 24.29% |
| Pretax Margin | 24.93% |
| Profit Margin | 19.35% |
| EBITDA Margin | 26.89% |
| EBIT Margin | 24.29% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 54.00, which amounts to a dividend yield of 2.05%.
| Dividend Per Share | 54.00 |
| Dividend Yield | 2.05% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | 0.82% |
| Shareholder Yield | 2.86% |
| Earnings Yield | 3.01% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 22, 2022 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |